Integra Lifesciences Holdings Corp (NASDAQ: IART) is -59.89% lower on its value in year-to-date trading and has touched a low of $16.96 and a high of $45.42 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IART stock was last observed hovering at around $17.14 in the last trading session, with the day’s gains setting it 0.33%.
Currently trading at $17.47, the stock is -4.31% and -20.95% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.79 million and changing 1.93% at the moment leaves the stock -45.28% off its SMA200. IART registered -54.09% loss for a year compared to 6-month loss of -49.84%. The firm has a 50-day simple moving average (SMA 50) of $21.8174 and a 200-day simple moving average (SMA200) of $31.80485.
The stock witnessed a -14.86% gain in the last 1 month and extending the period to 3 months gives it a -39.23%, and is 0.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.03% over the week and 4.07% over the month.
Integra Lifesciences Holdings Corp (IART) has around 5329 employees, a market worth around $1.36B and $1.57B in sales. Current P/E ratio is 59.20 and Fwd P/E is 6.97. Profit margin for the company is 1.51%. Distance from 52-week low is 3.01% and -61.54% from its 52-week high. The company has generated returns on investments over the last 12 months (0.67%).
The EPS is expected to shrink by -20.99% this year
348.0 institutions hold shares in Integra Lifesciences Holdings Corp (IART), with institutional investors hold 110.84% of the company’s shares. The shares outstanding are 78.17M, and float is at 65.06M with Short Float at 7.02%. Institutions hold 95.14% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.25 million shares valued at $327.92 million. The investor’s holdings represent 14.4766 of the IART Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 7.77 million shares valued at $226.5 million to account for 9.999 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 5.5 million shares representing 7.0734 and valued at over $160.23 million, while WELLINGTON MANAGEMENT GROUP LLP holds 4.9997 of the shares totaling 3.89 million with a market value of $113.25 million.
Integra Lifesciences Holdings Corp (IART) Insider Activity
The most recent transaction is an insider sale by Mosebrook Jeffrey, the company’s SVP, Fin & Princ Acct Officer. SEC filings show that Mosebrook Jeffrey sold 1,191 shares of the company’s common stock on Aug 19 ’24 at a price of $21.58 per share for a total of $25701.0. Following the sale, the insider now owns 36088.0 shares.
Integra Lifesciences Holdings Corp disclosed in a document filed with the SEC on May 23 ’24 that ESSIG STUART (Exec. Chairman of the Board) bought a total of 52,641 shares of the company’s common stock. The trade occurred on May 23 ’24 and was made at $28.49 per share for $1.5 million. Following the transaction, the insider now directly holds 0.49 million shares of the IART stock.
Still, SEC filings show that on May 21 ’24, HILL BARBARA B (Director) acquired 36,350 shares at an average price of $27.40 for $1.0 million. The insider now directly holds 36,350 shares of Integra Lifesciences Holdings Corp (IART).
